AAAAAA

   
Results: 1-15 |
Results: 15
EXISTING AND NEW CRITERIA FOR BIOEQUIVALENCE EVALUATION OF NEW CONTROLLED-RELEASE (CR) PRODUCTS OF CARBAMAZEPINE
Authors: BIALER M ARCAVI L SUSSAN S VOLOSOV A YACOBI A MOROS D LEVITT B LAOR A
Citation: M. Bialer et al., EXISTING AND NEW CRITERIA FOR BIOEQUIVALENCE EVALUATION OF NEW CONTROLLED-RELEASE (CR) PRODUCTS OF CARBAMAZEPINE, Epilepsy research, 32(3), 1998, pp. 371-378
BIOEQUIVALENCE OF TOPICAL DERMATOLOGICAL DOSAGE FORMS - METHODS OF EVALUATION OF BIOEQUIVALENCE
Authors: SHAH VP FLYNN GL YACOBI A MAIBACH HI BON C FLEISCHER NM FRANZ TJ KAPLAN SA KAWAMOTO J LESKO LJ MARTY JP PERSHING LK SCHAEFER H SEQUEIRA JA SHRIVASTAVA SP WILKIN J WILLIAMS RL
Citation: Vp. Shah et al., BIOEQUIVALENCE OF TOPICAL DERMATOLOGICAL DOSAGE FORMS - METHODS OF EVALUATION OF BIOEQUIVALENCE, Pharmaceutical research, 15(2), 1998, pp. 167-171
CRITERIA TO ASSESS IN-VIVO PERFORMANCE AND BIOEQUIVALENCE OF GENERIC CONTROLLED-RELEASE FORMULATIONS OF CARBAMAZEPINE
Authors: BIALER M YACOBI A MOROS D LEVITT B HOULE JM MUNSAKA MS
Citation: M. Bialer et al., CRITERIA TO ASSESS IN-VIVO PERFORMANCE AND BIOEQUIVALENCE OF GENERIC CONTROLLED-RELEASE FORMULATIONS OF CARBAMAZEPINE, Epilepsia, 39(5), 1998, pp. 513-519
THE EFFECT OF TAZOBACTAM ON THE PHARMACOKINETICS AND THE ANTIBACTERIAL ACTIVITY OF PIPERACILLIN IN DOGS
Authors: ZAGHLOUL I KUCK N YACOBI A
Citation: I. Zaghloul et al., THE EFFECT OF TAZOBACTAM ON THE PHARMACOKINETICS AND THE ANTIBACTERIAL ACTIVITY OF PIPERACILLIN IN DOGS, International journal of pharmaceutics, 153(1), 1997, pp. 115-121
CONVERSION OF DIMETHOXYMETHYL-DIPHENYLBARBITURIC ACID (DMMDPB) TO DIPHENYLBARBITURIC ACID (DPB) IN THE RAT
Authors: RAINES A FLOCKHART D DRETCHEN KL SINGH A THACKER D YACOBI A MOROS D LEVITT BH ABERNETHY D
Citation: A. Raines et al., CONVERSION OF DIMETHOXYMETHYL-DIPHENYLBARBITURIC ACID (DMMDPB) TO DIPHENYLBARBITURIC ACID (DPB) IN THE RAT, The FASEB journal, 10(3), 1996, pp. 895-895
EVALUATION OF ORALLY-ADMINISTERED HIGHLY VARIABLE DRUGS AND DRUG FORMULATIONS
Authors: SHAH VP YACOBI A BARR WH BENET LZ BREIMER D DOBRINSKA MR ENDRENYI L FAIRWEATHER W GILLESPIE W GONZALEZ MA HOOPER J JACKSON A LESKO LJ MIDHA KK NOONAN PK PATNAIK R WILLIAMS RL
Citation: Vp. Shah et al., EVALUATION OF ORALLY-ADMINISTERED HIGHLY VARIABLE DRUGS AND DRUG FORMULATIONS, Pharmaceutical research, 13(11), 1996, pp. 1590-1594
INVALIDITY OF THE INTRAVENOUS MG-LOAD TEST IN PATIENTS WITH CROHNS-DISEASE OF THE SMALL-BOWEL
Authors: COHEN L YACOBI A
Citation: L. Cohen et A. Yacobi, INVALIDITY OF THE INTRAVENOUS MG-LOAD TEST IN PATIENTS WITH CROHNS-DISEASE OF THE SMALL-BOWEL, Magnesium-Bulletin, 18(4), 1996, pp. 87-89
ANALYSIS OF ENLOPLATIN BY LIQUID-CHROMATOGRAPHY AND OF PLATINUM BY ATOMIC-ABSORPTION SPECTROMETRY IN VARIOUS BIOLOGICAL-FLUIDS
Authors: AMORUSI P LESSARD D BANSAL SK SELINGER K YACOBI A TONELLI AP
Citation: P. Amorusi et al., ANALYSIS OF ENLOPLATIN BY LIQUID-CHROMATOGRAPHY AND OF PLATINUM BY ATOMIC-ABSORPTION SPECTROMETRY IN VARIOUS BIOLOGICAL-FLUIDS, Journal of pharmaceutical and biomedical analysis, 12(8), 1994, pp. 1023-1033
DOSE PROPORTIONALITY OF BISOPROLOL ENANTIOMERS IN HUMANS AFTER ORAL-ADMINISTRATION OF THE RACEMATE
Authors: DUTTA A LANC R BEGG E ROBSON R SIA L DUKART G DESJARDINS R YACOBI A
Citation: A. Dutta et al., DOSE PROPORTIONALITY OF BISOPROLOL ENANTIOMERS IN HUMANS AFTER ORAL-ADMINISTRATION OF THE RACEMATE, Journal of clinical pharmacology, 34(8), 1994, pp. 829-836
OPPORTUNITIES FOR INTEGRATION OF PHARMACOKINETICS, PHARMACODYNAMICS, AND TOXICOKINETICS IN RATIONAL DRUG DEVELOPMENT
Authors: PECK CC BARR WH BENET LZ COLLINS J DESJARDINS RE FURST DE HARTER JG LEVY G LUDDEN T RODMAN JH SANATHANAN L SCHENTAG JJ SHAH VP SHEINER LB SKELLY JP STANSKI DR TEMPLE RJ VISWANATHAN CT WEISSINGER J YACOBI A
Citation: Cc. Peck et al., OPPORTUNITIES FOR INTEGRATION OF PHARMACOKINETICS, PHARMACODYNAMICS, AND TOXICOKINETICS IN RATIONAL DRUG DEVELOPMENT, Journal of clinical pharmacology, 34(2), 1994, pp. 111-119
PHARMACOKINETICS OF TAZOBACTAM M1 METABOLITE AFTER ADMINISTRATION OF PIPERACILLIN TAZOBACTAM IN SUBJECTS WITH RENAL IMPAIRMENT/
Authors: HALSTENSON CE WONG MO JOHNSON CA ZIMMERMAN SW ONORATO JJ KEANE WF DOEPNER M SIA L TANTILLO K BANSAL S KUYE O YACOBI A FAULKNER R LATHIA CD
Citation: Ce. Halstenson et al., PHARMACOKINETICS OF TAZOBACTAM M1 METABOLITE AFTER ADMINISTRATION OF PIPERACILLIN TAZOBACTAM IN SUBJECTS WITH RENAL IMPAIRMENT/, Journal of clinical pharmacology, 34(12), 1994, pp. 1208-1217
RELATIONSHIP BETWEEN PLASMA-CONCENTRATIONS OF 3'-DEOXY-3'-FLUOROTHYMIDINE (ALOVUDINE) AND ANTIRETROVIRAL ACTIVITY IN 2 CONCENTRATION-CONTROLLED TRIALS
Authors: FLEXNER C VANDERHORST C JACOBSON MA POWDERLY W DUNCANSON F GANES D BARDITCHCROVO PA PETTY BG BARON PA ARMSTRONG D BRICMONT P KUYE O YACOBI A DESJARDINS R POLSKY B
Citation: C. Flexner et al., RELATIONSHIP BETWEEN PLASMA-CONCENTRATIONS OF 3'-DEOXY-3'-FLUOROTHYMIDINE (ALOVUDINE) AND ANTIRETROVIRAL ACTIVITY IN 2 CONCENTRATION-CONTROLLED TRIALS, The Journal of infectious diseases, 170(6), 1994, pp. 1394-1403
PHARMACOKINETIC COMPARISON OF LEUCOVORIN AND LEVOLEUCOVORIN
Authors: ZITTOUN J TONELLI AP MARQUET J DEGIALLULY E HANCOCK C YACOBI A JOHNSON JB
Citation: J. Zittoun et al., PHARMACOKINETIC COMPARISON OF LEUCOVORIN AND LEVOLEUCOVORIN, European Journal of Clinical Pharmacology, 44(6), 1993, pp. 569-573
POPULATION PHARMACODYNAMIC MODELING OF DRUG-INDUCED ANEMIA
Authors: GANES D BANSAL S JOHNSON D LEAL M NICOLAU G YACOBI A
Citation: D. Ganes et al., POPULATION PHARMACODYNAMIC MODELING OF DRUG-INDUCED ANEMIA, Journal of pharmaceutical sciences, 82(5), 1993, pp. 546-549
ANALYTICAL METHODS VALIDATION - BIOAVAILABILITY, BIOEQUIVALENCE AND PHARMACOKINETIC STUDIES - CONFERENCE REPORT
Authors: SHAH VP MIDHA KK DIGHE S MCGILVERAY IJ SKELLY JP YACOBI A LAYLOFF T VISWANATHAN CT COOK CE MCDOWALL RD PITTMAN KA SPECTOR S ALBERT KS BOLTON S DOBRINSKA M DOUB W EICHELBAUM M FINDLAY JWA GALLICANO K GARLAND W HARDY DJ HULSE JD KARNES HT LANGE R MASON WD MCKAY G ORMSBY E OVERPECK J PLATTENBERG HD SHIU G SITAR D SORGEL F STEWART JT VISWANATHAN CT YUH L
Citation: Vp. Shah et al., ANALYTICAL METHODS VALIDATION - BIOAVAILABILITY, BIOEQUIVALENCE AND PHARMACOKINETIC STUDIES - CONFERENCE REPORT, European journal of drug metabolism and pharmacokinetics, 16(4), 1991, pp. 249-255
Risultati: 1-15 |